SCHEMBL25600261

SCHEMBL25600261

CCCOC(=O)C1=C(O)c2cc(Cl)ccc2CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
TDP1 Q9NUW8 2/20 0.39
ESR1 P03372 1/20 0.39
CHRM1 P11229 1/20 0.39
TSHR P16473 1/20 0.39
SLC6A2 P23975 1/20 0.39
KDR P35968 1/20 0.39
SLC6A15 Q9H2J7 1/20 0.39
MAPK14 Q16539 1/20 0.38
KDM4E B2RXH2 4/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
SPR P35270 1/20 0.37
SRD5A1 P18405 1/20 0.37
SRD5A2 P31213 1/20 0.37
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.36
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25549318 0.90 KDM4E (0.45) ALDH1A1HPGDTDP1SLC6A2SLC6A15
SCHEMBL21474580 0.82 SLC6A3 (0.44) ALDH1A1HPGDSLC6A2KDM4EKMT2A
SCHEMBL25598740 0.74 MAPK14 (0.45) ALDH1A1HPGDTDP1TSHRMAPK14
SCHEMBL15675574 0.71 ALDH1A1 (0.62) ALDH1A1HPGDTDP1ESR1CHRM1
SCHEMBL21478257 0.70 ALDH1A1 (0.49) ALDH1A1HPGDTDP1KDM4ELMNA
SCHEMBL21474573 0.69 ALDH1A1 (0.41) ALDH1A1HPGDTDP1TSHRSLC6A15
SCHEMBL21474668 0.69 POLB (0.39) ALDH1A1HPGDTDP1SLC6A15KDM4E
SCHEMBL20267208 0.69 ALDH1A1 (0.54) ALDH1A1HPGDTDP1ESR1CHRM1
SCHEMBL10487722 0.69 ALDH1A1 (0.54) ALDH1A1HPGDTDP1ESR1CHRM1
SCHEMBL12447830 0.69 SLC6A3 (0.44) ALDH1A1HPGDSLC6A2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159439-A1 ARYLAMIDES AND METHODS OF USE THEREOF GENZYME CORPORATION 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159439-A1 ARYLAMIDES AND METHODS OF USE THEREOF CFTR, AADAC, ARSA ALDH1A1 1072/4885HPGD 1090/4885TDP1 3414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.